Eliza M Park1, Shari Gelber2, Shoshana M Rosenberg2, Davinia S E Seah3, Lidia Schapira4, Steven E Come5, Ann H Partridge6. 1. Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: leeza_park@med.unc.edu. 2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. 3. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Sacred Heart Supportive and Palliative Care, St. Vincent's Hospital, Sydney, New South Wales, Australia. 4. Department of Medicine, Stanford University Medical Center, Palo Alto, CA. 5. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 6. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Abstract
BACKGROUND: Young adults with cancer experience disruptions in their normal developmental trajectories and commonly experience psychologic distress related to their diagnoses. Young women with metastatic breast cancer (MBC) are at particular risk of adverse mental health outcomes. OBJECTIVE: We sought to determine the prevalence of and factors associated with anxiety and depression symptoms in young women with newly diagnosed de novo MBC. METHODS: A total of 54 women with newly diagnosed de novo MBC were identified from an ongoing, prospective, multicenter cohort of women diagnosed with breast cancer at age <40. Depression and anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). Items assessing socio-demographics, physical symptom burden, social support, and disease and treatment history, with complementary medical record review, were used to assess variables potentially associated with anxiety and depression symptoms. RESULTS: Mean HADS Depression score was 4.4 (standard deviation = 3.7) and mean HADS Anxiety score was 7.9 (standard deviation = 5.0). Eleven (20%) women scored ≥8 on the HADS Depression subscale, the suggested threshold for depression/anxiety screening, and 24 (44%) women scored ≥8 on the HADS Anxiety subscale. In a multivariable model of anxiety, higher physical symptom scores (odds ratio = 4.41, p = 0.005) was significantly associated with higher anxiety scores. None of the other variables improved the model fit. CONCLUSION: In this study, a considerable proportion of young women with newly diagnosed MBC experienced anxiety symptoms, although depression was less common. Future strategies focused on distress reduction in young MBC patients should focus on physical symptom management as well as anxiety identification and management.
BACKGROUND: Young adults with cancer experience disruptions in their normal developmental trajectories and commonly experience psychologic distress related to their diagnoses. Young women with metastatic breast cancer (MBC) are at particular risk of adverse mental health outcomes. OBJECTIVE: We sought to determine the prevalence of and factors associated with anxiety and depression symptoms in young women with newly diagnosed de novo MBC. METHODS: A total of 54 women with newly diagnosed de novo MBC were identified from an ongoing, prospective, multicenter cohort of women diagnosed with breast cancer at age <40. Depression and anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). Items assessing socio-demographics, physical symptom burden, social support, and disease and treatment history, with complementary medical record review, were used to assess variables potentially associated with anxiety and depression symptoms. RESULTS: Mean HADS Depression score was 4.4 (standard deviation = 3.7) and mean HADS Anxiety score was 7.9 (standard deviation = 5.0). Eleven (20%) women scored ≥8 on the HADS Depression subscale, the suggested threshold for depression/anxiety screening, and 24 (44%) women scored ≥8 on the HADS Anxiety subscale. In a multivariable model of anxiety, higher physical symptom scores (odds ratio = 4.41, p = 0.005) was significantly associated with higher anxiety scores. None of the other variables improved the model fit. CONCLUSION: In this study, a considerable proportion of young women with newly diagnosed MBC experienced anxiety symptoms, although depression was less common. Future strategies focused on distress reduction in young MBCpatients should focus on physical symptom management as well as anxiety identification and management.
Authors: L B Wenzel; D L Fairclough; M J Brady; D Cella; K M Garrett; B C Kluhsman; L A Crane; A C Marcus Journal: Cancer Date: 1999-11-01 Impact factor: 6.860
Authors: David W Kissane; Brenda Grabsch; Anthony Love; David M Clarke; Sidney Bloch; Graeme C Smith Journal: Aust N Z J Psychiatry Date: 2004-05 Impact factor: 5.744
Authors: Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell Journal: J Clin Oncol Date: 2008-07-10 Impact factor: 44.544
Authors: Matthew E Nilsson; Paul K Maciejewski; Baohui Zhang; Alexi A Wright; Elizabeth D Trice; Anna C Muriel; Robert J Friedlander; Karen M Fasciano; Susan D Block; Holly G Prigerson Journal: Cancer Date: 2009-01-15 Impact factor: 6.860
Authors: Florence K L Tangka; Sujha Subramanian; Madeleine Jones; Patrick Edwards; Timothy Flanigan; Yevgeniya Kaganova; Kevin W Smith; Cheryll C Thomas; Nikki A Hawkins; Juan Rodriguez; Temeika Fairley; Gery P Guy Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Doris M Howell; Kelly Metcalfe; Shiying Kong; Joanne Stephen; Ivo A Olivotto; Nancy Baxter; Christine M Friedenreich; Ellen Warner; Mohammed Reza Akbari; Kristine McBain; Steven Narod; May Lynne Quan Journal: Breast Cancer Res Treat Date: 2022-04-24 Impact factor: 4.872
Authors: E C Karademas; P Simos; R Pat-Horenczyk; I Roziner; K Mazzocco; B Sousa; G Stamatakos; G Tsakou; F Cardoso; D Frasquilho; E Kolokotroni; C Marzorati; J Mattson; A J Oliveira-Maia; K Perakis; G Pettini; L Vehmanen; P Poikonen-Saksela Journal: J Clin Psychol Med Settings Date: 2022-04-30
Authors: Nancy A Borstelmann; Tamryn F Gray; Shari Gelber; Shoshana Rosenberg; Yue Zheng; Meghan Meyer; Kathryn J Ruddy; Lidia Schapira; Steven Come; Virginia Borges; Tamara Cadet; Peter Maramaldi; Ann H Partridge Journal: Support Care Cancer Date: 2022-01-28 Impact factor: 3.603
Authors: Lindsay D Strehle; Kathryn L G Russart; Valerie A Burch; Corena V Grant; Leah M Pyter Journal: Am J Physiol Regul Integr Comp Physiol Date: 2022-08-22 Impact factor: 3.210
Authors: Marloes E Clarijs; Jacob Thurell; Friedrich Kühn; Carin A Uyl-de Groot; Elham Hedayati; Maria M Karsten; Agnes Jager; Linetta B Koppert Journal: Cancers (Basel) Date: 2021-05-12 Impact factor: 6.639